申泽雪,李树仁,李文静,唐子健

• 1:华北理工大学研究生院
• 2:河北省人民医院心内科
• 3:河北医科大学研究生院

摘要(Abstract)：

<正>主动脉瓣狭窄(aortic stenosis,AS)是65岁以上人群最常见的心脏瓣膜疾病~([1])。过去对于晚期或症状性AS的治疗选择仅限于外科主动脉瓣置换术(surgical aorticvalve replacement,SAVR);近十年来,经导管主动脉瓣置换术(transcatheter aortic valve replacement,TAVR)在此类患者

关键词(KeyWords)： 经导管主动脉瓣置换术;经股动脉入径;经心尖入径;经主动脉入径;经颈动脉入径

Abstract:

Keywords:

基金项目(Foundation): 政府资助临床医学优秀人才项目（361003）

作者(Author): 申泽雪,李树仁,李文静,唐子健

参考文献(References)：

• [1] Raptis DA, Beal MA, Kraft DC, et al. Transcatheter aortic valve replacement:alternative access beyond the femoral arterial approach. Radiographics, 2019, 39(1):30-43.
• [2] Serruys PW, Modolo R, Reardon M, et al. One-year outcomes of patients with severe aortic stenosis and an STS-PROM of less than three percent in the SURTAVI trial. EuroIntervention, 2018,14(8):877-883.
• [3] Cahill TJ, Chen M, Hayashida K, et al. Transcatheter aortic valve implantation:current status and future perspectives. Eur Heart J, 2018, 39(28):2625-2634.
• [4] Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36):2739-2791.
• [5]中华医学会心血管病学分会结构性心脏病学组，中国医师协会心血管内科医师分会结构性心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识.中国介入心脏病学杂志，2018, 26(12):661-668.
• [6] Barbanti M, Tamburino C, D’Errigo P, et al. Five-year outcomes of transfemoral transcatheter aortic valve replacement or surgical aortic valve replacement in a real world population:f inal results f rom the OBSERVANT study. Circ Cardiovasc Interv, 2019, 12(7):e007825.
• [7] Seppelt PC, Zappel J, Weiler H, et al. Aortic valve replacement in patients with preexisting liver disease:transfemoral approach with favorable survival. Catheter Cardiovasc Interv, 2020, 95(1):54-64.
• [8] Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med, 2017, 376(14):1321-1331.
• [9] Bonaros N, Petzina R, Cocchieri R, et al. Transaortic transcatheter aortic valve implantation as a first-line choice or as a last resort? An analysis based on the ROUTE registry. Eur J Cardiothorac Surg, 2017, 51(5):919-926.
• [10]秦悦，徐臣年，杨剑.经心尖入径二尖瓣置换术的临床应用及展望.中国介入心脏病学杂志，2019, 27(2):115-118.
• [11] Al-Hijji MA, Zack CJ, Nkomo VT, et al. Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement. Catheter Cardiovasc Interv, 2019, 94(5):738-744.
• [12] Nakatsuka D, Tabata M. Transapical approach for transcatheter aortic valve implantation. Ann Cardiothorac Surg, 2017, 6(5):553-554.
• [13] Overtchouk P, Modine T. Transcatheter aortic valve implantation(TAVI)using the transapical approach//Advances in treatments for aortic valve and root diseases. Springer, Cham, 2018:331-347.
• [14] Okoh AK, Kang N, Haik N, et al. Clinical and functional outcomes associated with age after transapical transcatheter aortic valve replacement. Innovations(Phila), 2019, 14(2):151-158.
• [15] Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med, 2016, 374(17):1609-1620.
• [16] Doshi R, Shah P, Meraj PM. In-hospital outcomes comparison of transfemoral vs transapical transcatheter aortic valve replacement in propensity-matched cohorts with severe aortic stenosis. Clin Cardiol, 2018, 41(3):326-332.
• [17] Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective,randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis:the STACCATO trial.EuroIntervention, 2012, 8(3):383-389.
• [18] Agha AM, Burt JR, Beetler D, et al. The association between transcatheter aortic valve replacement(TAVR)approach and new-onset bundle branch blocks. Cardiol Ther, 2019, 8(2):357-364.
• [19] Overtchouk P, Modine T. A comparison of alternative access routes for transcatheter aortic valve implantation. Expert Rev Cardiovasc Ther, 2018, 16(10):749-756.
• [20] Bapat V, Khawaja MZ, Attia R, et al. Transaortic transcatheter aortic valve implantation using edwards sapien valve:a novel approach. Catheter Cardiovasc Interv, 2012, 79(5):733-740.
• [21] Romano M, Frank D, Cocchieri R, et al. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry. Interact Cardiovasc Thorac Surg, 2017, 25(5):757-764.
• [22] Arai T, Romano M, Lefèvre T, et al. Direct comparison of feasibility and safety of transfemoral versus transaortic versus transapical transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2016, 9(22):2320-2325.
• [23] Amrane H, Porta F, Van Boven AV, et al. A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team. EuroIntervention, 2017, 13(2):168-176.
• [24] Cocchieri R, Petzina R, Romano M, et al. Outcomes after transaortic transcatheter aortic valve implantation:long-termfindings from the European ROUTE. Eur J Cardiothorac Surg,2018, 55(4):737-743.
• [25] Folliguet TA, Teiger E, Beurtheret S, et al. Carotid versus femoral access for transcatheter aortic valve implantation:a propensity score inverse probability weighting study. Eur J Cardiothorac Surg, 2019, 56(6):1140-1146.
• [26] Overtchouk P, Folliguet T, Pinaud F, et al. Transcarotid approach for transcatheter aortic valve replacement with the Sapien 3prosthesis:a multicenter French registry. JACC Cardiovasc Interv,2019, 12(5):413-419.
• [27]潘文志，周达新，张晓春，等.经颈动脉途径行经导管主动脉瓣置换术治疗重度主动脉瓣狭窄的安全性和有效性.中华心血管病杂志，2018, 46(3):198-202.
• [28] Beve M, Auffret V, Soulami RB, et al. Comparison of the transarterial and transthoracic approaches in nontransfemoral transcatheter aortic valve implantation. Am J Cardiol, 2019, 123(9):1501-1509.
• [29] Chamandi C, Abi-Akar R, Rodés-Cabau J, et al. Transcarotid compared with other alternative access routes for transcatheter aortic valve replacement. Circ Cardiovasc Interv, 2018, 11(11):e006388.
• [30] Amer MR, Mosleh W, Joshi S, et al. Comparative outcomes of transcarotid and trans-subclavian transcatheter aortic valve replacement. Ann Thorac Surg, 2020, 109(1):49-56.
• [31] Hysi I, Gommeaux A, Pécheux M, et al. Axillary transcatheter aortic valve replacement in patients with peripheral vascular disease. Semin Thorac Cardiovasc Surg, 2019, 31(2):175-180.
• [32] Takagi H, Hari Y, Nakashima K, et al. Comparison of early and midterm outcomes af ter transsubclavian/axillary versus transfemoral, transapical, or transaortic transcatheter aortic valve implantation. Heart Lung, 2019, 48(6):519-529.
• [33] Biasco L, Ferrari E, Pedrazzini G, et al. Access sites for TAVI:patient selection criteria, technical aspects, and outcomes. Front Cardiovasc Med, 2018, 5:88.
• [34] Uflacker A, Lim S, Ragosta M, et al. Transcaval aortic access for percutaneous thoracic aortic aneurysm repair:initial human experience. J Vasc Interv Radiol, 2015, 26(10):1437-1441.
• [35] Lederman RJ, Greenbaum AB, Rogers T, et al. Anatomic suitability for transcaval access? Based on computed tomography.JACC Cardiovasc Interv, 2017, 10(1):1-10.
• [36] Greenbaum AB, O’Neill WW, Paone G, et al. Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients. J Am Coll Cardiol, 2014, 63(25):2795-2804.
• [37] Paone G, Eng M, Kabbani LS, et al. Transcatheter aortic valve replacement:comparing transfemoral, transcarotid, and transcaval access. Ann Thorac Surg, 2018, 106(4):1105-1112.